KR20190030850A - Platycodon radix composition containing high protocatechuic acid, epicatechin, and oleic acid and enhanced inhibition activities of alpha-glucosidase and pancreatic lipase, and preparation method thereof - Google Patents
Platycodon radix composition containing high protocatechuic acid, epicatechin, and oleic acid and enhanced inhibition activities of alpha-glucosidase and pancreatic lipase, and preparation method thereof Download PDFInfo
- Publication number
- KR20190030850A KR20190030850A KR1020170118380A KR20170118380A KR20190030850A KR 20190030850 A KR20190030850 A KR 20190030850A KR 1020170118380 A KR1020170118380 A KR 1020170118380A KR 20170118380 A KR20170118380 A KR 20170118380A KR 20190030850 A KR20190030850 A KR 20190030850A
- Authority
- KR
- South Korea
- Prior art keywords
- enhanced
- bellflower
- epicatechin
- acid
- alpha
- Prior art date
Links
- YQUVCSBJEUQKSH-UHFFFAOYSA-N 3,4-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 title claims abstract description 28
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 title claims abstract description 24
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 title claims abstract description 24
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 title claims abstract description 24
- 239000005642 Oleic acid Substances 0.000 title claims abstract description 24
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 title claims abstract description 24
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 title claims abstract description 24
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 title claims abstract description 24
- 102000019280 Pancreatic lipases Human genes 0.000 title claims abstract description 23
- 108050006759 Pancreatic lipases Proteins 0.000 title claims abstract description 23
- 108010028144 alpha-Glucosidases Proteins 0.000 title claims abstract description 23
- 229940116369 pancreatic lipase Drugs 0.000 title claims abstract description 23
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 title claims abstract description 22
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 title claims abstract description 22
- 102100024295 Maltase-glucoamylase Human genes 0.000 title claims abstract description 22
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 title claims abstract description 22
- 235000012734 epicatechin Nutrition 0.000 title claims abstract description 22
- 235000006751 Platycodon Nutrition 0.000 title claims description 10
- 229930189914 platycodon Natural products 0.000 title claims description 10
- 230000000694 effects Effects 0.000 title abstract description 13
- 239000000203 mixture Substances 0.000 title description 7
- 230000005764 inhibitory process Effects 0.000 title description 2
- 238000002360 preparation method Methods 0.000 title description 2
- 241000357613 Platycodon Species 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 42
- 238000004519 manufacturing process Methods 0.000 claims abstract description 16
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 14
- 238000000034 method Methods 0.000 claims abstract description 13
- 244000274050 Platycodon grandiflorum Species 0.000 claims abstract description 12
- 235000013376 functional food Nutrition 0.000 claims abstract description 10
- 230000003178 anti-diabetic effect Effects 0.000 claims abstract description 8
- 230000003579 anti-obesity Effects 0.000 claims abstract description 8
- 239000003472 antidiabetic agent Substances 0.000 claims abstract description 5
- 241000332371 Abutilon x hybridum Species 0.000 claims description 40
- 238000000855 fermentation Methods 0.000 claims description 22
- 230000004151 fermentation Effects 0.000 claims description 22
- 230000032683 aging Effects 0.000 claims description 12
- 241000186660 Lactobacillus Species 0.000 claims description 9
- 239000004480 active ingredient Substances 0.000 claims description 9
- 229940039696 lactobacillus Drugs 0.000 claims description 9
- 240000001929 Lactobacillus brevis Species 0.000 claims description 7
- 235000013957 Lactobacillus brevis Nutrition 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 5
- 235000013361 beverage Nutrition 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 235000015110 jellies Nutrition 0.000 claims description 2
- 239000008274 jelly Substances 0.000 claims description 2
- 230000005070 ripening Effects 0.000 claims description 2
- 235000006753 Platycodon grandiflorum Nutrition 0.000 abstract description 3
- 239000003963 antioxidant agent Substances 0.000 abstract description 2
- 235000006708 antioxidants Nutrition 0.000 abstract description 2
- 239000004615 ingredient Substances 0.000 abstract description 2
- 230000000052 comparative effect Effects 0.000 description 21
- 238000002835 absorbance Methods 0.000 description 17
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 16
- 230000002292 Radical scavenging effect Effects 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 239000004310 lactic acid Substances 0.000 description 10
- 239000002253 acid Substances 0.000 description 8
- 235000014655 lactic acid Nutrition 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 7
- 239000012153 distilled water Substances 0.000 description 7
- 239000013642 negative control Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 238000010025 steaming Methods 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 6
- 229930003935 flavonoid Natural products 0.000 description 6
- 150000002215 flavonoids Chemical class 0.000 description 6
- 235000017173 flavonoids Nutrition 0.000 description 6
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 6
- 235000011957 flavonols Nutrition 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000013543 active substance Substances 0.000 description 5
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- -1 browning Chemical class 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 150000007946 flavonol Chemical class 0.000 description 4
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 4
- 229930182490 saponin Natural products 0.000 description 4
- 235000017709 saponins Nutrition 0.000 description 4
- 150000007949 saponins Chemical class 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 241000226211 Salminus brasiliensis Species 0.000 description 3
- 244000052616 bacterial pathogen Species 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 102000038379 digestive enzymes Human genes 0.000 description 3
- 108091007734 digestive enzymes Proteins 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 150000007965 phenolic acids Chemical class 0.000 description 3
- 239000012064 sodium phosphate buffer Substances 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- NHTMVDHEPJAVLT-UHFFFAOYSA-N Isooctane Chemical compound CC(C)CC(C)(C)C NHTMVDHEPJAVLT-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 239000000538 analytical sample Substances 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- JVSWJIKNEAIKJW-UHFFFAOYSA-N dimethyl-hexane Natural products CCCCCC(C)C JVSWJIKNEAIKJW-UHFFFAOYSA-N 0.000 description 2
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 235000019629 palatability Nutrition 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- LSHVYAFMTMFKBA-PZJWPPBQSA-N (+)-catechin-3-O-gallate Chemical compound O([C@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-PZJWPPBQSA-N 0.000 description 1
- FTVWIRXFELQLPI-ZDUSSCGKSA-N (S)-naringenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 FTVWIRXFELQLPI-ZDUSSCGKSA-N 0.000 description 1
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
- RVBUGGBMJDPOST-UHFFFAOYSA-N 2-thiobarbituric acid Chemical compound O=C1CC(=O)NC(=S)N1 RVBUGGBMJDPOST-UHFFFAOYSA-N 0.000 description 1
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 241001125840 Coryphaenidae Species 0.000 description 1
- JINCXMJGROALLO-UHFFFAOYSA-N Deapio-platycodin D Natural products CC1OC(OC2C(O)C(O)COC2OC(=O)C34CCC(C)(C)CC3C5=CCC6C7(C)CC(O)C(OC8CC(CO)C(O)C(O)C8O)C(CO)(CO)C7CCC6(C)C5(C)CC4O)C(O)C(O)C1OC9OCC(O)C(O)C9O JINCXMJGROALLO-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 240000006024 Lactobacillus plantarum Species 0.000 description 1
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- XHKCYIRZWRRXNG-UHFFFAOYSA-N Platycodin D3 Natural products OC1C(O)C(OC2C(C(OC3C(C(O)(CO)CO3)O)C(O)CO2)O)C(C)OC1OC1C(O)C(O)COC1OC(=O)C1(C(CC2(C)C3(C)CCC4C5(CO)CO)O)CCC(C)(C)CC1C2=CCC3C4(C)CC(O)C5OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C(O)C1O XHKCYIRZWRRXNG-UHFFFAOYSA-N 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 241000245165 Rhododendron ponticum Species 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- BDCUGHMNUOTFKX-YJGMJMKZSA-N [(2s,3r,4s,5s)-3-[(2s,3r,4s,5r,6s)-5-[(2s,3r,4s,5r)-4-[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-3,5-dihydroxyoxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-4,5-dihydroxyoxan-2-yl] (4ar,5r,6ar,6as,6br,8ar,9r,10r,11s,12ar,14bs)-5,11-dihy Polymers O([C@H]1[C@@H](O)C[C@]2(C)[C@H]3CC=C4[C@@H]5CC(C)(C)CC[C@@]5([C@@H](C[C@@]4(C)[C@]3(C)CC[C@H]2[C@@]1(CO)C)O)C(=O)O[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H]([C@@H]([C@@H](O)[C@H]1O)O[C@H]1[C@@H]([C@@H](O[C@H]2[C@@H]([C@@](O)(CO)CO2)O)[C@H](O)CO1)O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O BDCUGHMNUOTFKX-YJGMJMKZSA-N 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 229940101006 anhydrous sodium sulfite Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- HCKUIVZXCXTBEH-PSRBGVDOSA-N deapio-platycodin D Chemical compound O([C@H]1[C@@H](O)C[C@]2(C)[C@H]3CC=C4[C@@H]5CC(C)(C)CC[C@@]5([C@@H](C[C@@]4(C)[C@]3(C)CC[C@H]2C1(CO)CO)O)C(=O)O[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H]([C@@H]([C@@H](O)[C@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)CO1)O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HCKUIVZXCXTBEH-PSRBGVDOSA-N 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000011990 functional testing Methods 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- LVJJFMLUMNSUFN-UHFFFAOYSA-N gallocatechin gallate Natural products C1=C(O)C=C2OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C1OC(=O)C1=CC(O)=C(O)C(O)=C1 LVJJFMLUMNSUFN-UHFFFAOYSA-N 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 229940072205 lactobacillus plantarum Drugs 0.000 description 1
- 229940040461 lipase Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- WGEYAGZBLYNDFV-UHFFFAOYSA-N naringenin Natural products C1(=O)C2=C(O)C=C(O)C=C2OC(C1)C1=CC=C(CC1)O WGEYAGZBLYNDFV-UHFFFAOYSA-N 0.000 description 1
- 229940117954 naringenin Drugs 0.000 description 1
- 235000007625 naringenin Nutrition 0.000 description 1
- 229930019673 naringin Natural products 0.000 description 1
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 1
- 229940052490 naringin Drugs 0.000 description 1
- 229930003811 natural phenol Natural products 0.000 description 1
- 230000000324 neuroprotective effect Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000021315 omega 9 monounsaturated fatty acids Nutrition 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- XHKCYIRZWRRXNG-COMVGSAYSA-N platycodin D3 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@H]1[C@@H](O)C[C@]2(C)[C@H]3CC=C4[C@@H]5CC(C)(C)CC[C@@]5([C@@H](C[C@@]4(C)[C@]3(C)CC[C@H]2C1(CO)CO)O)C(=O)O[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H]([C@@H]([C@@H](O)[C@H]1O)O[C@H]1[C@@H]([C@@H](O[C@H]2[C@@H]([C@@](O)(CO)CO2)O)[C@H](O)CO1)O)C)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O XHKCYIRZWRRXNG-COMVGSAYSA-N 0.000 description 1
- BDCUGHMNUOTFKX-DDRWPPTGSA-N polygalacin D Polymers O([C@H]1[C@@H](O)C[C@]2(C)[C@H]3CC=C4[C@@H]5CC(C)(C)CC[C@@]5([C@@H](C[C@@]4(C)[C@]3(C)CC[C@H]2[C@]1(CO)C)O)C(=O)O[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H]([C@@H]([C@@H](O)[C@H]1O)O[C@H]1[C@@H]([C@@H](O[C@H]2[C@@H]([C@@](O)(CO)CO2)O)[C@H](O)CO1)O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O BDCUGHMNUOTFKX-DDRWPPTGSA-N 0.000 description 1
- DJPJACADAIGMKF-CTELNEMLSA-N polygalacin-D Natural products O=C(O[C@H]1[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@H]3[C@H](O)[C@@H](O[C@@]4(O)[C@H](O)[C@@](O)(CO)CO4)[C@H](O)CO3)[C@H](C)O2)[C@@H](O)[C@@H](O)CO1)[C@@]12[C@H](O)C[C@@]3(C)[C@@]4(C)[C@@H]([C@]5(C)[C@H]([C@@](CO)(C)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O)C5)CC4)CC=C3[C@@H]1CC(C)(C)CC2 DJPJACADAIGMKF-CTELNEMLSA-N 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-N trans-cinnamic acid Chemical compound OC(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/332—Promoters of weight control and weight loss
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/18—Lipids
- A23V2250/186—Fatty acids
- A23V2250/188—Oleic acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/121—Brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A23Y2220/13—
-
- A23Y2220/67—
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
본 발명은 프로토카테큐산, 에피카테킨 및 올레산이 강화되고 증진된 알파-글로코시다제 및 췌장 리파아제 저해활성을 갖는 도라지 및 그 제조방법에 관한 것이다. 더 상세하게는 도라지를 증숙, 락토바실러스 플란타륨 P1201 균주와 락토바실러스 브레비스 BMK184 균주의 혼합종균으로 발효, 및 숙성하여 제조된 프로토카테큐산, 에피카테킨 및 올레산이 강화되고 증진된 알파-글루코시다제 및 췌장 리파아제 저해활성을 갖는 도라지 및 그 제조방법에 관한 것이다.The present invention relates to platycetic acid, epicatechin and alpha- glucosidase with enhanced and enhanced oleic acid and platelets having pancreatic lipase inhibitory activity, and a process for producing the same. More particularly, the present invention relates to a process for producing a fermentation broth, which comprises fermenting bellflower with a mixed seed of Lactobacillus plantai P1201 strain and Lactobacillus brevis BMK184, and cultivating and aging the protocatechuic acid, epicatechin and oleic acid enhanced and enhanced alpha-glucosidase, The present invention relates to a bellflower having pancreatic lipase inhibitory activity and a method for producing the same.
도라지(Platycodon grandiflorum)는 길경, 길경채, 질경 또는 산도라지라고 하며 산과 들에서 자라고 뿌리는 굵고 줄기는 곧으며 높이는 40 ∼ 100cm이다. 도라지는 당질을 약 90% 이상 함유하고 있고 단백질이 약 2.5%, 지질 약 0.1%로 보고되어있다. Platycodon grandiflorum ) is called Gil Kyung, Gil-gyeonggi, jeongyeong, or mountain bellflower. It grows in mountains and fields. Its roots are thick, stem is straight, and its height is 40 ~ 100cm. Platycodon contains about 90% or more carbohydrate, about 2.5% protein, and about 0.1% lipid.
도라지는 latycodin D, platycodin D3, polygalacin D, deapioplatycodin D 형태의 사포닌을 함유하고 이들 사포닌이 항암, 뇌신경세포 보호작용, 항산화 작용을 나타낸다고 알려져 있다. 이와 같이 도라지 활성성분과 관련하여 사포닌에 대한 연구가 주를 이루고 있고 그 외의 활성성분에 대해서는 잘 알려져 있지 않는 실정이다 (등록특허 10-1732036호, 등록특허 10-0915860호). 따라서 사포닌 이외의 도라지 활성성분의 강화 방법의 개발 필요성이 크게 대두되고 있다.The bellflower contains saponins of latycodin D, platycodin D3, polygalacin D and deapioplatycodin D, and these saponins are known to exhibit anticancer, neuroprotective and antioxidant activities. As described above, saponins are mainly studied in relation to the active ingredient of platycodon, and other active ingredients are not well known (Patent No. 10-1732036, No. 10-0915860). Therefore, there is a great need to develop a method for strengthening the active ingredient of the plant material other than saponin.
프로토카테큐산(Protocatechuic acid)은 항산화 활성 및 항염 활성을 갖는 주요 폴리페놀이며, 항암 효과도 있다고 알려져 있다. 에피카테킨은 천연 페놀이며 항산화 활성을 갖는 주요 플라보놀이다. 올레산은 불포화지방산으로 혈압 강하 및 유방암 발병 감소 활성을 갖는 것으로 알려져 있다.Protocatechuic acid is a major polyphenol with antioxidant activity and anti-inflammatory activity and is known to have anticancer effect. Epicatechin is a natural phenol and a major flavonol with antioxidant activity. It is known that oleic acid is an unsaturated fatty acid and has activity to lower blood pressure and reduce the incidence of breast cancer.
그러나 프로토카테큐산, 에피카테킨 및 올레산과 같은 활성성분이 강화된 도라지의 제조방법이 알려진 바는 없다.However, there is no known method for producing bellflower having enhanced active ingredients such as protocatechuic acid, epicatechin and oleic acid.
이에 본 발명자들은 종래 기술의 요구에 부응하기 위한 연구를 지속한 결과, 증숙, 특정 유산균 혼합종균 발효 및 고온 숙성 기술을 접목하여 프로토카테큐산, 에피카테킨 및 올레산이 강화되고 동시에 알파-글루코시다제 저해활성과 췌장 리파아제 저해활성이 증진된 도라지를 제조하여 본 발명을 완성하게 되었다.Accordingly, the present inventors have continued their studies to meet the needs of the prior art, and as a result, they have found that the addition of lactic acid bacteria, specific lactic acid bacterial fermentation, and high temperature aging technology to enhance protocatechuic acid, epicatechin and oleic acid and simultaneously inhibit alpha-glucosidase And pancreatic lipase inhibitory activity were improved, thereby completing the present invention.
따라서 본 발명의 목적은 프로토카테큐산, 에피카테킨 및 올레산이 강화되고 증진된 알파-글루코시다제 저해활성과 췌장 리파아제 저해활성을 갖는 도라지의 제조방법을 제공하는 것이다.Accordingly, it is an object of the present invention to provide a method for preparing a broth having an inhibitory activity of alpha-glucosidase and an activity of inhibiting pancreatic lipase, which are enhanced and enhanced by protocatechuic acid, epicatechin and oleic acid.
본 발명의 또 다른 목적은 상기 제조방법에 의해 제조된, 프로토카테큐산, 에피카테킨 및 올레산이 강화되고 증진된 알파-글루코시다제 저해활성과 췌장 리파아제 저해활성을 갖는 도라지를 제공하는 것이다.Yet another object of the present invention is to provide platycetic acid, epicatechin and oleic acid, which are enhanced and enhanced by alpha-glucosidase inhibitory activity and pancreatic lipase inhibitory activity, which are produced by the above-described method.
본 발명의 또 다른 목적은 상기 도라지를 유효성분으로 포함하는 항산화 활성, 항당뇨 활성 및 항비만 활성을 갖는 기능성식품을 제공하는 것이다.It is still another object of the present invention to provide a functional food having antioxidant activity, antidiabetic activity and anti-obesity activity, which comprises the abovementioned bellflower as an active ingredient.
상기 목적을 달성하기 위하여, 본 발명은 하기와 같은 단계들을 포함하는 프로토카테큐산, 에피카테킨 및 올레산이 강화되고 증진된 알파-글루코시다제 저해활성과 췌장 리파아제 저해활성을 갖는 도라지의 제조방법을 제공한다:In order to accomplish the above object, the present invention provides a method for preparing a bellflower having the activity of inhibiting alpha-glucosidase and the activity of inhibiting pancreatic lipase, which is enhanced and enhanced by protocatechy acid, epicatechin and oleic acid, :
ⅰ) 도라지를 증숙하는 단계;I) steaming the bellflower;
ⅱ) 증숙된 도라지를 락토바실러스 플란타륨 P1201 균주와 락토바실러스 브레비스 BMK184 균주의 혼합종균으로 발효하는 단계; 및Ii) fermenting the cooked bellflower with a mixed seed of Lactobacillus plantai P1201 strain and Lactobacillus brevis BMK184 strain; And
ⅲ) 발효된 도라지를 고온에서 숙성시키는 단계.Iii) aging the fermented bellflower at a high temperature.
단계 ⅰ): Step i): 증숙Steam
도라지를 증숙(steaming process)한다. Steaming the bellflower.
본 발명에서 도라지는 2년근 이상을 사용한다. 도라지를 흐르는 물에 3회 세척하고 물기를 제거한 후 증숙한다. In the present invention, the bellflower is used for two years or more. Wash the bellflower three times in flowing water, remove the water and cook.
증숙은 통상의 찜기와 같은 증숙기를 사용하여 수행할 수 있으며, 100℃에서 30~120분간 수행한다. The steaming may be carried out using a steam boiler such as a conventional steamer, and is carried out at 100 ° C for 30 to 120 minutes.
증숙시간이 30분 미만인 경우 충분한 증숙이 진행되지 않아 발효 또는 숙성과 같은 후속 단계가 원활하지 않을 수 있고 잡균의 오염이 발생될 수 있다. 120분 초과하여 증숙될 경우는 오랜 열처리로 도라지의 영양성분이 파괴될 수 있다.If the steaming time is less than 30 minutes, sufficient steaming does not proceed and subsequent steps such as fermentation or aging may not be smooth and contamination of germs may occur. If it is cooked more than 120 minutes, the nutritional ingredient of the bellflower may be destroyed by long heat treatment.
단계 ⅱ): 혼합종균 발효Step ii): Mixed seed fermentation
증숙된 도라지를 혼합종균으로 발효한다. The matured bellflower is fermented into mixed seeds.
본 발명의 제조방법에서 혼합종균으로는 락토바실러스 플란타륨 P1201 균주와 락토바실러스 브레비스 BMK184 균주를 혼합하여 사용된다. In the production method of the present invention, the mixed seed is used by mixing Lactobacillus plantai P1201 strain and Lactobacillus brevis BMK184 strain.
본 발명에서 혼합종균을 구성하는 하나의 균주인 락토바실러스 플란타륨 P1201 균주는 본 발명자가 분리동정하여 국립농업과학원 농업유전자원센터 (KACC)에 2013년 8월 13일자로 기탁한 균주(수탁번호 KACC91848P)로서 생균제제능이 우수하고 생리활성물질 생산성이 우수하나, 동형유산발효(homo-lactic acid fermentation) 유산균으로 단독 발효 시 유산이 과다하게 생성되어 이를 감세할 필요가 있었다. The strain Lactobacillus plantai P1201, which constitutes a mixed strain in the present invention, is a strain deposited with the National Institute of Agricultural Science and Technology (KACC) on Aug. 13, 2013 KACC91848P), which has excellent probiotics and high productivity of physiologically active substances, but lactic acid bacteria of homo-lactic acid fermentation were required to be excreted excessively during fermentation alone.
본 발명에서 혼합종균을 구성하는 또 다른 하나의 균주인 락토바실러스 BMK184 균주는 또한 본 발명자가 분리동정하여 국립농업과학원 농업유전자원센터에 2016년 12월 12일에 기탁한(수탁번호 KACC 92156P) 균주로, 가바(GABA)의 생산성 및 생리활성물질의 생산성이 탁월하나 이형유산발효(hetero-lactic acid fermentation) 유산균으로 단독 발효 시 유산 생성이 미흡하였으나, 락토바실러스 플란타륨 P1201 균주와 혼합종균으로 사용시, 상기 2종의 균주의 발효 특성이 상호 보완되어 상승작용을 나타내었다 (특허출원 2017-0068747호).The strain Lactobacillus BMK184, another strain that constitutes the mixed seeds in the present invention, was also isolated from the strain (KACC 92156P, Accession No. KACC 92156P) deposited on Dec. 12, 2016 at the National Institute of Agricultural Science and Technology GABA productivity and productivity of physiologically active substances were excellent. However, lactic acid fermentation with hetero-lactic acid fermentation did not produce lactic acid during fermentation alone. However, when lacto-Bacillus plantai P1201 was used as a mixed germ , The fermentation characteristics of the two strains were complementary to each other and exhibited a synergistic action (Patent Application No. 2017-0068747).
락토바실러스 플란타륨 P1201 및 락토바실러스 브레비스 BMK184 균주는 맥아엑기스 액체배지에서 종균으로 배양하며, 배양 전 또는 후 1:1 비율로 혼합하여 혼합종균을 제조한다.Lactobacillus plantai P1201 and Lactobacillus brevis BMK184 are cultivated as seeds in a malt extract liquid medium and mixed at a ratio of 1: 1 before or after culturing to produce mixed seeds.
발효는 상기 혼합종균 배양액을 증숙된 도라지에 2 ∼ 10%(v/w) 농도로 접종하여 25 ~ 40℃에서 2 ~ 7일간 발효시키는 것으로 수행될 수 있다. The fermentation can be carried out by inoculating the mixed seed culture with the fermented broth at a concentration of 2 to 10% (v / w) and fermenting at 25 to 40 ° C for 2 to 7 days.
혼합종균 접종량이 2%(v/w) 미만 일 경우에는 발효 속도가 지연될 수 있고 발효 온도가 25℃ 미만일 경우 발효기간이 길어져 잡균의 오염을 초래하고 40℃를 초과할 경우에는 균주의 생육이 정지될 수 있고 발효 기간이 2일 미만일 경우 발효 기간이 충분하지 않아 생리활성물질 등의 생성이 저조하게 될 수 있으며, 7일 초과일 경우 역시 과 발효에 의해 생리활성물질이 분해될 수 있다.If the inoculum is less than 2% (v / w), the fermentation rate may be delayed. If the fermentation temperature is less than 25 ° C, the fermentation period is prolonged to cause contamination of germs. If the fermentation period is less than 2 days, the fermentation period is not sufficient and the production of physiologically active substances may be poor. If the fermentation period is over 7 days, the physiologically active substance may be decomposed by over fermentation.
ⅲ) 숙성Iii) Aging
발효된 도라지를 고온에서 숙성시킨다.The fermented bellflower is aged at high temperature.
숙성은 60 ∼ 80℃의 고온에서 5 ∼ 10일간 숙성시킨다. The ripening is aged at high temperature of 60 ~ 80 ℃ for 5 ~ 10 days.
숙성 온도가 60℃ 미만이거나 숙성 기간이 5일 미만일 경우 숙성이 원활히 이루어지지 않으며, 숙성온도가 80℃ 초과하거나 숙성 기산이 10일 초과일 경우 생산된 생리활성물질이 분해되어 함량이 감소될 수 있다.If the aging temperature is less than 60 ° C or the aging period is less than 5 days, the aging is not smoothly performed. If the aging temperature is more than 80 ° C or the aging period is more than 10 days, the produced physiologically active substance may be decomposed and the content may be decreased .
숙성은, 제한되지는 않으나, 발효된 도라지를 밀폐 용기에 담아서 수행될 수 있다. The fermentation may be performed by, but not limited to, placing the fermented broth in a closed container.
본 발명의 상기와 같은 단계를 거쳐 제조된 도라지는 유산 생성이 적정하게 이루어져 기호성이 유지되면서도 프로토카테큐산, 에피카테킨 및 올레산과 같은 생리활성성분이 강화될뿐만 아니라 항산화 활성, 항당뇨 및 항비만 활성이 현저히 증진되었다 (시험예 3 및 4).The bellflower produced through the above steps of the present invention has proper lactic acid production to maintain its palatability, and not only strengthens physiologically active components such as protocatechyme, epicatechin and oleic acid, but also antioxidant activity, antidiabetic activity and anti-obesity activity (Test Examples 3 and 4).
본 발명의 또 다른 목적에 따라서, 본 발명은 상기 제조방법에 의해 제조되고, 프로토카테큐산, 에피카테킨 및 올레산이 강화되고 증진된 알파-글루코시다제 저해활성과 췌장 리파아제 저해활성을 갖는 도라지를 제공한다. According to yet another object of the present invention, there is provided a bellflower having the alpha-glucosidase inhibitory activity and the pancreatic lipase inhibiting activity, which are produced by the above-mentioned method and are enhanced and enhanced by protocatechuic acid, epicatechin and oleic acid .
본 발명의 또 다른 목적에 따라서, 상기 도라지를 유효성분으로 포함하는 항산화 활성, 항당뇨 활성 및 항비만 활성을 갖는 기능성식품을 제공한다. According to another object of the present invention, there is provided a functional food having antioxidative activity, antidiabetic activity and anti-obesity activity, wherein said bellflower is an active ingredient.
본 발명에서 기능성식품은 본 발명의 도라지를 건조하여 분쇄하여 분말로 제조하거나, 과립, 환, 음료, 젤리 등의 형태의 제품을 제조될 수 있다.In the present invention, the functional food may be prepared by drying and pulverizing the bellflower of the present invention to produce a powder, or a product in the form of a granule, a ring, a beverage, or a jelly.
본 발명의 제조방법은, 통상의 방법에 비하여, 프로토카테큐산, 에피카테킨 및 올레산의 함량 및 알파-글루코시다제 저해활성과 췌장 리파아제 저해활성이 현저히 증진된 도라지를 생산케 한다. The production method of the present invention produces bellflower with significantly increased contents of protocatechy acid, epicatechin and oleic acid as well as alpha-glucosidase inhibitory activity and pancreatic lipase inhibitory activity compared with the conventional method.
본 발명에 따른 도라지는 프로토카테큐산, 에피카테킨 및 올레산의 함량 이 현저히 증진되어 있고, 더불어 우수한 알파-글루코시다제 저해활성과 췌장 리파아제 저해활성도 가져서, 항산화, 항당뇨 및 항비만 효과가 우수하여, 기능성 식품·의약품의 소재로 사용될 수 있다.The content of protocatechuic acid, epicatechin and oleic acid is remarkably improved, and also excellent alpha-glucosidase inhibitory activity and pancreatic lipase inhibitory activity are exhibited. Thus, It can be used as a material for food and medicine.
본 발명에 따른 기능성식품은 우수한 항당뇨 및 항비만 기능성을 가져서, 지방생성 억제효과, 체중 조절, 콜레스테롤 저하, 고지혈증 개선, 동맥경화 완화, 당뇨병 완화, 혈액순환 개선, 면역력 개선용으로 유용하다.The functional food according to the present invention has excellent antidiabetic and anti-obesity functions, and is useful for inhibiting fat production, controlling body weight, decreasing cholesterol, improving hyperlipidemia, alleviating atherosclerosis, alleviating diabetes, improving blood circulation, and improving immunity.
도 1은 본 발명의 제조방법의 공정도의 일례와 각 단계에 따라 제조된 도라지의 사진이다.
도 2는 본 발명에 따른 도라지의 항산화 활성을 나타낸 것이다. 도 2a는 DPPH 라디칼 소거활성을 나타낸 것이며, 도 2b는 ABTS 라디칼 소거활성을 나타낸 것이며, 도 2c는 하이드록실 라디칼 소거활성을 나타낸 것이다.
도 3은 본 발명에 따른 도라지의 소화효소 저해활성을 나타낸 것이다. 도 3a는 알파-글루코시다아제 저해활성을 나타낸 것이며, 도 3b는 췌장-리파아제 저해활성을 나타낸 것이다.Fig. 1 is an example of a process diagram of the manufacturing method of the present invention and a photograph of a bellflower produced according to each step.
Fig. 2 shows the antioxidative activity of the rhizome of the present invention. FIG. 2A shows the DPPH radical scavenging activity, FIG. 2B shows the ABTS radical scavenging activity, and FIG. 2C shows the hydroxyl radical scavenging activity.
Fig. 3 shows digestive enzyme inhibitory activity of rhododendron according to the present invention. Fig. 3a shows the alpha-glucosidase inhibitory activity, and Fig. 3b shows the pancreatic-lipase inhibitory activity.
다음의 실시예들에 의해 본 발명이 더 상세히 설명된다. 이들 실시예는 본 발명을 예시하기 위한 것이며, 본 발명의 범위가 이들에 의해 제한되어서는 안된다.The present invention will be described in more detail by the following examples. These examples are for illustrating the present invention, and the scope of the present invention should not be limited by them.
실시예Example
제조예Manufacturing example . 도라지 제조. Bellflower manufacturing
2년∼5년근 도라지 1kg을 흐르는 수돗물에 깨끗이 3회 세척 후 물기를 완전히 제거하고, 찜 솥에 적당량의 물과 함께 100℃에서 1시간 쪄서 증숙 도라지를 제조하였다. 락토바실러스 플란타륨 P1201 및 락토바실러스 브레비스 BMK184 균주는 맥아엑기스 액체배지에서 종균으로 배양하고, 배양 전 또는 후 1:1 비율로 혼합한 혼합종균을 5%(v/w)로 증숙 도라지에 접종하고 30℃에서 7일간 발효시켜 발효 도라지를 제조하고, 발효 도라지를 밀폐용기에 담고 70℃에서 7일간 숙성시켜 본 발명에 따른 도라지 (실시예)를 완성하였다 (도 1).Two to five years later, 1 kg of bellflower was washed thoroughly with tap water three times, and water was completely removed. Steamed potatoes were steamed at 100 ° C for one hour in an appropriate amount of water. Lactobacillus plantai P1201 and Lactobacillus brevis BMK184 were cultivated as seeds in a malt extract liquid medium, and mixed seedlings mixed at a ratio of 1: 1 before or after cultivation were inoculated into a vinegar broth at 5% (v / w) The fermented Dorado was fermented at 30 ° C for 7 days to prepare fermented Dorado, and the fermented Dorado was placed in a closed container and aged at 70 ° C for 7 days to complete the platycodon according to the present invention (Fig. 1).
제조된 도라지의 pH는 pH 미터기를 사용하여 측정하였고 총산도는 중화적정법을 통해 수행하여 젖산으로 환산하여 표 1에 나타내었다.The pH of the prepared bellflower was measured using a pH meter, and the total acidity was measured by neutralization titration and converted into lactic acid, and the results are shown in Table 1.
본 발명에 따라 제조된 도라지는 pH와 총산도는 각각 3.71과 0.64%로 혼합종균 사용시 적정한 산도가 생성되었다. 락토바실러스 플란타륨 단독 발효 시에는 산이 과다가 생성되며, 반대로 락토바실러스 브레비스 단독 발효 시에는 산 생성력이 약하다. 과다 산이 생성되면 신맛이 강화하여 기호성에 문제가 발생할 수 있고 산 생성력이 약할 경우 잡균 등의 오염 기회가 높아진다. The pH and total acidity of the bellflower prepared according to the present invention were 3.71 and 0.64%, respectively. Lactobacillus plantarum alone produces excess acid during fermentation, whereas lactobacillus brevis alone produces weak acidity. When excess acid is produced, the sour taste may be strengthened and palatability problems may occur. If the acid production is weak, chances of contamination with germs are increased.
시험예Test Example 1. 도라지의 올레산 함량 분석 1. Analysis of oleic acid content in bellflower
상기 제조예에서 제조된 본 발명에 따른 도라지(실시예)와, 비교를 위하여 각 단계의 도라지 즉, 세척된 원재료 도라지 (비교예 1), 증숙 단계까지만 거친 증숙 도라지 (비교예 2), 및 발효 단계까지만 거친 발효 도라지 (비교예 3) 각각의 올레산 함량을 분석하였다.For comparison, the broodstock of each step, i.e., the washed raw material broth (Comparative Example 1), the steaming broth (Comparative Example 2) roasted only to the steaming stage, and the fermentation The oleic acid content of each of the fermented dorados (Comparative Example 3) was analyzed.
분석시료는 각각의 도라지를 55℃에서 약 3일간 건조시키고 분말화를 통해 분말을 제조 후, 각각의 분말 1g에 0.5 N 메탄올성 NaOH 3ml를 가하고 100℃에서 10분간 가온하여 지방산과 글리세롤을 가수분해시켰다. 가수분해에 이어 삼불화붕소(BF3) 2ml를 가하여 교반한 후 30분간 다시 가온 과정을 거쳐 지방산의 메틸에스테르화를 진행하였다. 반응이 끝난 후 이소옥탄 1ml를 첨가하고 격렬히 흔든 후 이소옥탄층만을 회수하여 무수아황산나트륨과 함께 탈수한 뒤 0.45㎛ 막필터 (Dismic-25CS)로 여과하여 가스크로마토그래피로 분석하였고 그 결과를 표 2에 나타내었다. The analytical sample was prepared by drying each of the bellflower at 55 ° C for about 3 days, preparing powders by pulverization, adding 3 ml of 0.5 N methanolic NaOH to 1 g of each powder, heating the mixture at 100 ° C for 10 minutes to hydrolyze the fatty acid and glycerol . Hydrolysis was followed by addition of 2 ml of boron trifluoride (BF 3 ), stirring was continued for 30 minutes, and the methyl esterification of the fatty acid was proceeded. After the reaction was completed, 1 ml of isooctane was added and the mixture was vigorously shaken. Only the isooctane layer was recovered, dehydrated with anhydrous sodium sulfite, filtered through a 0.45 μm membrane filter (Dismic-25CS) and analyzed by gas chromatography. .
상기 표 2에 나타낸 바와 같이, 비교예 1~3과 비교하여, 본 발명에 따른 실시예의 도라지는 오메가-9 불포화지방산인 올레산의 함량이 현저하게 증가하였음을 확인할 수 있다.As shown in Table 2, as compared with Comparative Examples 1 to 3, it was confirmed that the content of oleic acid as the omega-9 unsaturated fatty acid was remarkably increased in the platycodon of the example according to the present invention.
시험예Test Example 2. 도라지의 생리활성성분 함량 분석 2. Analysis of physiologically active ingredient content of bellflower
생리활성성분인 총 플라보노이드, 갈변도, 페놀릭산 및 플라보놀을 분석하였다.Total flavonoids, browning, phenolic acid and flavonol were analyzed.
<분석시료 준비><Preparation of analytical sample>
상기 시험예 1에서와 같이 준비된 각각의 도라지 분말 10g에 50% 발효주정 10 ml를 첨가하여 상온(20±5℃)에서 24시간 추출하고 3,000 rpm의 속도로 원심분리하여 상등액만을 취하여 추출물을 제조하고 이 추출물을 시료로 하여 총 플라보노이드, 페놀릭산 및 플라보놀을 분석하였고, 각각의 추출물을 60℃에서 감압농축 및 동결건조 후, 0, 0.25, 0.5, 1.0 mg/ml 농도로 제조한 시료를 대상으로 하여 항산화 활성과 소화효소 저해활성 분석을 하였다.10 ml of a 50% fermented alcohol was added to 10 g of each of the bellflower powder prepared as in Test Example 1, and the mixture was extracted at room temperature (20 ± 5 ° C) for 24 hours and centrifuged at a rate of 3,000 rpm to prepare an extract. Total extracts were analyzed by filtration, freeze - drying at 60 ℃, and samples prepared at 0, 0.25, 0.5 and 1.0 mg / ml concentration. And antioxidant activity and digestive enzyme inhibitory activity were analyzed.
<총 플라보노이드 함량 및 갈변도 분석> <Total flavonoid content and browning analysis>
총 플라보노이드 함량은 Davis 변법으로 측정하였다. 상기에서 준비된 시료 0.1 ml에 1 N NaOH 0.01 ml를 첨가한 후 디에틸렌글리콜 1.0 ml를 첨가하여 37℃에서 1시간 방치 후 420nm 흡광도를 측정하였다. 이때 총 플라보노이드 함량은 루틴(rutin)의 최종 농도를 0.25, 0.5, 1.0 mg/ml로 제조하여 작성한 표준곡선으로부터 함량을 구하였고 그 결과는 표 3에 나타내었다.Total flavonoid contents were measured by Davis transformation. After adding 0.01 ml of 1 N NaOH to 0.1 ml of the sample prepared above, 1.0 ml of diethylene glycol was added, and the mixture was allowed to stand at 37 ° C for 1 hour, and the absorbance at 420 nm was measured. The total flavonoid content of rutin was 0.25, 0.5 and 1.0 mg / ml, and the content was determined from the standard curves. The results are shown in Table 3.
갈변도는 각각의 도라지 분말 1g에 증류수 10 ml를 첨가하여 25℃에서 1시간 추출 후 상등액만을 분광광도계(Spectronic 2D)를 이용하여 420 nm에서 측정하여 그 결과는 표 3에 나타내었다.10 mg of distilled water was added to 1 g of each of the blooming powders, followed by extraction at 25 ° C. for 1 hour. The supernatant was measured at 420 nm using a spectrophotometer (Spectronic 2D). The results are shown in Table 3.
표 3에 나타낸 바와 같이, 비교예 1~3과 비교하여, 본 발명에 따른 실시예의 도라지의 총 플라보노이드 함량은 약 1.6 ~ 5배 증진되었고, 갈변물질도 약 2배 이상 증진되었다.As shown in Table 3, as compared with Comparative Examples 1 to 3, the total flavonoid content of the platycodon of the examples according to the present invention was increased by about 1.6 to 5 times and the browning material was also increased by about twice.
〈페놀릭산 및 플라보놀 화합물 함량〉<Content of phenolic acid and flavonol compound>
페놀릭산과 플라보놀 함량 분석은 상기에서 준비된 각각의 시료에 대해 HPLC(high performance liquid chromatography)를 사용하여 분석하였다. Analysis of phenolic acid and flavonol content was carried out using HPLC (high performance liquid chromatography) for each of the samples prepared above.
분석 컬럼은 XBridgeTM C18(4.6×250 mm, 5 μm, Waters Corp., Milford, MA, USA) 컬럼을 사용하였고 0.5% 글라시알 아세트산 (glacial acetic acid, 이동상 용매 A)와 100% 메탄올(이동상 용매 B)을 0 ~ 100% 선형 구배(linear gradient)로 30℃에서 60분간 1분당 1 ml의 속도로 가동하면서 UV 검출기로 페놀릭산(280 nm)과 플라보놀(270 nm)을 검출하였고 결과는 표 4와 표 5에 나타내었다.The analytical column used was XBridge ™ C18 (4.6 × 250 mm, 5 μm, Waters Corp., Milford, Mass., USA) column and eluted with 0.5% glacial acetic acid (mobile phase solvent A) and 100% (280 nm) and flavonol (270 nm) were detected with a UV detector at a rate of 1 ml per minute for 60 minutes at 30 ° C in a linear gradient of 0-100% 4 and Table 5, respectively.
표 4에 나타낸 바와 같이, 비교예 1~3과 비교하여, 본 발명에 따른 실시예의 도라지의 페놀릭산 화합물의 함량은 증진되었고, 특히 프로토카테큐산(protocatechuic acid)의 함량은 약 1.5 ~ 2배 증진되었다.As shown in Table 4, the content of the phenolic acid compound of the platycodon of the examples according to the present invention was improved, and the content of protocatechuic acid was increased by about 1.5 to 2 times .
표 5에 나타낸 바와 같이, 비교예 1~3과 비교하여, 본 발명에 따른 실시예의 도라지의 플라보놀 화합물의 함량은 증진되었고, 특히 에피카테킨(epicatechin)의 함량은 약 2 ~ 4배 증진되었다.As shown in Table 5, the content of flavonol compounds in the bellflower of the examples according to the present invention was improved, and the content of epicatechin was increased about 2 to 4 times, in particular, as compared with Comparative Examples 1 to 3.
시험예Test Example 3. 도라지의 항산화 활성 분석 3. Antioxidant activity analysis of bellflower
본 발명에 따른 도라지의 항산화 활성은 DPPH, ABTS 및 OH 라디칼 소거활성을 측정하여 분석하였다. The antioxidative activity of the platycodon according to the present invention was measured by measuring DPPH, ABTS and OH radical scavenging activity.
DPPH 라디칼 소거활성은 상기에서 준비된 시료 (각각 0.25 mg/ml, 0.5 mg/ml, 1 mg/ml 농도 3가지) 0.2 ml에, DPPH 용액(1.5×10-4 M) 0.8 ml를 첨가하여 균일하게 혼합한 30분간 방치한 후 525 nm에서 흡광도를 측정하여 수행하였다. DPPH 라디칼 소거활성의 음성 대조구는 시료 대신 증류수를 사용하여 동일한 방법으로 진행하여 흡광도의 차이를 다음과 같은 식에 의해 백분율(%)로 산출하였으며, 그 결과를 도 2a에 도시하였다. To DPPH radical scavenging activity, 0.8 ml of DPPH solution (1.5 x 10 -4 M) was added to 0.2 ml of each of the samples prepared above (three kinds of 0.25 mg / ml, 0.5 mg / ml and 1 mg / ml concentration) After incubation for 30 minutes, the absorbance was measured at 525 nm. The negative control of DPPH radical scavenging activity proceeded in the same manner using distilled water instead of the sample, and the difference in absorbance was calculated as a percentage (%) by the following equation, and the result is shown in FIG.
라디칼 소거활성(%) = [1-(음성대조구 흡광도 ÷ 실험구 흡광도)]×100Radical scavenging activity (%) = [1- (negative control absorbance / experiment absorbance)] × 100
ABTS 라디칼 소거활성은 7 mM ABTS 시약 5 ml과 140 mM K2S2O8 (FW 270.3, Sigma 9392) 5 ml을 섞어 어두운 곳에 16시간 방치시켜 양이온 라디칼을 생성시킨 후, 이를 메탄올로 섞어 732 nm에서 대조구의 흡광도 값이 0.7±0.02가 되도록 조절한 ABTS 용액을 사용하였다. 시료 (각각 0.25 mg/ml, 0.5 mg/ml, 1 mg/ml 농도 3가지) 0.1 ml과 ABTS 용액 0.9 ml를 혼합하여 3분간 반응시키고 732 nm에서 흡광도를 측정하였다. ABTS 라디칼 저해활성 역시 음성 대조구는 시료 대신 증류수를 사용하여 동일한 방법으로 진행하여 흡광도의 차이를 상기 식에 의해 백분율(%)로 산출하였으며, 그 결과를 도 2b에 도시하였다. The ABTS radical scavenging activity was obtained by mixing 5 ml of 7 mM ABTS reagent and 5 ml of 140 mM K 2 S 2 O 8 (FW 270.3, Sigma 9392) in a dark place for 16 hours to produce a cation radical. And the absorbance of the control was adjusted to 0.7 ± 0.02. 0.1 ml of each sample (three kinds of concentrations of 0.25 mg / ml, 0.5 mg / ml and 1 mg / ml) and 0.9 ml of ABTS solution were mixed and reacted for 3 minutes and absorbance was measured at 732 nm. The ABTS radical inhibitory activity was also measured in the same manner using distilled water instead of the sample as the negative control, and the difference in absorbance was calculated as a percentage (%) according to the above equation. The results are shown in FIG. 2B.
하이드록실(OH) 라디칼 소거활성 측정은 10 mM FeSO4 .7H20-EDTA 0.2ml, 10 mM 2-데옥시리보스 0.2 ml, 10 mM H2O2 0.2 ml, 시료 (각각 0.25 mg/ml, 0.5 mg/ml, 1 mg/ml 농도 3가지) 1.4 ml 혼합한 뒤 37 ℃에서 4시간 동안 반응시켜 혼합액을 만든 후, 이 혼합액에 1% 티오바르비투르산(thiobarbituric acid)/증류수와 2.8% 트리클로로아세트산(trichloroaceric acid)/증류수를 각각 1 ml를 가하여 100 ℃에서 20분간 발색시켜 냉각시킨 후 520 nm에서 흡광도를 측정하여 행하였다. 하이드록실 라디칼 소거활성은 시료 용액의 첨가구와 무첨가구 사이의 흡광도의 차이를 상기 식에 의해 % 값을 산출하였고, 그 결과를 도 2c에 나타냈다.Hydroxyl (OH) radical scavenging activity was measured 10 mM FeSO 4. 7H 2 0-EDTA 0.2ml, 10 mM 2- deoxyribose 0.2 ml, 10 mM H 2 O 2 0.2 ml, samples (0.25 mg / ml, 0.5 mg / ml, 1 mg / ml concentration of each of three kinds) 1.4
도 2에 도시된 바와 같이, 본 발명에 따른 도라지는, 비교예 1~3에 비하여, DPPH 라디칼, ABTS 라디칼 및 하이드록실 라디칼의 소거활성이 모두 농도의존적으로 현저히 증진되었고, 특히 1 mg/ml 농도에서 실시예 도라지의 DPPH 라디칼 소거활성은 84.72%, ABTS 라디칼 소거활성은 82.97%, 하이드록실 라디칼 소거활성은 56.05%으로 매우 높게 나타났다.As shown in FIG. 2, Dorago according to the present invention significantly enhanced the scavenging activities of the DPPH radical, the ABTS radical and the hydroxyl radical in a concentration-dependent manner, compared with Comparative Examples 1 to 3, , The DPPH radical scavenging activity was 84.72%, the ABTS radical scavenging activity was 82.97%, and the hydroxyl radical scavenging activity was 56.05%.
시험예Test Example 4. 도라지의 소화효소 저해활성 검정 4. Digestive enzyme inhibition activity of bellflower
본 발명에 따른 도라지에 대해 항당뇨(당뇨 개선) 효과의 지표인 알파-글루코시다아제 저해활성을 검정하였고, 항비만(비만 개선) 지표인 췌장 리파아제 저해활성을 검정하였다. Alpha-glucosidase inhibitory activity, which is an index of anti-diabetic (diabetic) effect, was assayed on the rhizomes according to the present invention and the activity of inhibiting pancreatic lipase, which is an anti-obesity index, was examined.
<알파-글루코시다아제 저해활성>≪ Alpha-Glucosidase Inhibitory Activity >
알파-글루코시다아제 저해활성은 시료(각각 0.25 mg/ml, 0.5 mg/ml, 1 mg/ml 농도 3가지) 50 ㎕에 0.5 U/ml 알파-글루코시데이즈 효소액 50 ㎕를 첨가하고 여기에 200 mM 인산나트륨 완충액(pH 6.8) 50 ㎕를 혼합하여 37℃에서 10분간 예비 배양한 후, 인산나트륨 완충액(pH 6.8)을 100 ㎕ 가하여 37℃에서 10 분간 반응시켰다. 반응액에 100 mM Na2CO3 0.75 ml를 첨가하여 반응을 정지시키고 420 nm에서 흡광도를 측정하였으며 음성 대조구는 시료 대신 증류수를 사용하여 동일한 방법으로 진행하여 흡광도의 차이를 다음 식에 의해 백분율(%)로 산출하였으며, 그 결과를 도 3a에 도시하였다. 50 μl of 0.5 U / ml α-glucosidase enzyme solution was added to 50 μl of samples (three kinds of 0.25 mg / ml, 0.5 mg / ml and 1 mg / ml concentration, respectively) mM phosphate buffer solution (pH 6.8) were mixed and preliminarily cultured at 37 ° C for 10 minutes. 100 μl of sodium phosphate buffer (pH 6.8) was added and reacted at 37 ° C for 10 minutes. The reaction was stopped by adding 0.75 ml of 100 mM Na 2 CO 3 to the reaction mixture, and the absorbance at 420 nm was measured. Negative control was carried out in the same manner using distilled water instead of the sample, and the difference in absorbance was expressed as a percentage (% ). The results are shown in Fig. 3A.
알파-글루코시다아제 저해활성(%) =Alpha-glucosidase inhibitory activity (%) =
[1-(음성대조구 흡광도 ÷ 실험구 흡광도)] × 100 [1- (negative control absorbance / experimental absorbance)] × 100
도 3a에 도시된 바와 같이, 본 발명에 따른 본 발명에 따른 도라지는, 비교예 1~3에 비하여, 알파-글루코시다아제 저해활성이 농도의존적으로 증진되었고, 특히 1 mg/ml 농도 기준으로 약 1.5 ~ 5배 증진된 것을 확인할 수 있다 (도 3a).As shown in FIG. 3A, the platelet of the present invention according to the present invention showed an alpha-glucosidase inhibitory activity in a concentration-dependent manner, compared to Comparative Examples 1 to 3. In particular, about 1 mg / It can be confirmed that it is enhanced 1.5 to 5 times (FIG. 3A).
<췌장-리파아제 저해활성><Pancreatic-lipase inhibitory activity>
췌장-리파아제 저해활성은 시료(각각 0.25 mg/ml, 0.5 mg/ml, 1 mg/ml 농도 3가지) 50 ㎕, 1.0 U/ml 췌장 리파아제 효소액 50 ㎕, 200 mM 인산나트륨 완충액(pH 6.8) 50 ㎕를 혼합하여 37℃에서 10분간 예비 배양한 후, 인산나트륨 완충액(pH 6.8)을 100 ㎕ 가하여 37℃에서 10 분간 반응시켰다. 이 반응액에 100 mM Na2CO3 0.75 ml를 첨가하여 반응을 정지시키고 420 nm에서 흡광도를 측정하고 음성 대조구는 증류수를 사용하여 동일한 방법으로 진행하여 흡광도의 차이를 다음 식에 의해 백분율(%)로 산출하였으며, 그 결과를 도 3b에 도시하였다. 50 μl of 1.0 U / ml pancreatic lipase enzyme solution, 50 μl of 200 mM sodium phosphate buffer solution (pH 6.8) 50 μl of each sample (each of 0.25 mg / ml, 0.5 mg / ml and 1 mg / ml concentration of pancreatic-lipase inhibitory activity) Were mixed and pre-incubated at 37 占 폚 for 10 minutes. Then, 100 占 퐇 of a sodium phosphate buffer solution (pH 6.8) was added and reacted at 37 占 폚 for 10 minutes. The reaction was stopped by adding 0.75 ml of 100 mM Na 2 CO 3 to the reaction solution, and the absorbance at 420 nm was measured. Negative control was carried out in the same manner using distilled water, and the difference in absorbance was calculated by the following formula (% And the results are shown in FIG. 3B.
췌장-리파아제 저해활성(%) = Pancreatic-lipase inhibitory activity (%) =
[1 - (음성대조구 흡광도÷실험구 흡광도)]×100[1 - (negative control absorbance / experimental absorbance)] × 100
도 3b에 도시된 바와 같이, 비교예 1 및 2의 도라지는 췌장-리파아제 저해활성이 확인조차 되지 않았으며, 본 발명에 따른 본 발명에 따른 도라지는 비교예 3에 비하여도 농도의존적으로 증진된 췌장-리파아제 저해활성을 나타냈고 특히 1 mg/ml 농도 기준으로 2배 이상 증진된 것을 확인할 수 있다 (도 3b).As shown in FIG. 3B, the platelets of Comparative Examples 1 and 2 did not show any inhibitory activity against pancreatic-lipase, and the platycodon according to the present invention according to the present invention exhibited a concentration- -Lipase inhibitory activity, and in particular, it was confirmed that the concentration was increased more than two times based on the concentration of 1 mg / ml (FIG. 3b).
상기 기능성 검정 결과들로부터, 본 발명의 제조방법에 따라 제조된 도라지는 프로토카테큐산, 에피카테킨 및 올레산과 같은 생리활성성분이 증진될 뿐만 아니라 항산화 활성, 알파-글루코시다제 저해활성과 췌장 리파아제 저해활성도 증진되어 우수한 항산화, 항당뇨 및 항비만 활성을 갖는 기능성 식품의 소재로 유용하다는 것을 알 수 있다.From the above functional test results, it can be seen that the bellflower prepared according to the production method of the present invention not only enhances physiologically active components such as protocatechuic acid, epicatechin and oleic acid, but also exhibits antioxidant activity, alpha-glucosidase inhibitory activity and pancreatic lipase inhibitory activity And thus it is useful as a material for functional foods having excellent antioxidant, antidiabetic and anti-obesity activities.
Claims (7)
ⅰ) 도라지를 100℃에서 30~120분간 증숙하는 단계;
ⅱ) 증숙된 도라지를 락토바실러스 플란타륨 P1201 균주와 락토바실러스 브레비스 BMK184 균주의 혼합종균으로 발효하는 단계; 및
ⅲ) 발효된 도라지를 숙성시키는 단계를 포함하는 것인 방법.
A method for the production of bellflower having enhanced alpha-glucosidase inhibitory activity and pancreatic lipase inhibitory activity, which are enhanced and enhanced by protocatechyme, epicatechin and oleic acid,
I) ripening the bellflower at 100 DEG C for 30 to 120 minutes;
Ii) fermenting the cooked bellflower with a mixed seed of Lactobacillus plantai P1201 strain and Lactobacillus brevis BMK184 strain; And
Iii) aging the fermented bellflower.
The method according to claim 1, wherein the fermentation in step ii) is carried out by inoculating the cultured broth of the mixed broth with a concentration of 2 to 10% (v / w) in the broth, and fermenting the broth at 25 to 40 ° C for 2 to 7 days. A process for the production of bellflower having enhanced alpha - glucosidase inhibitory activity and pancreatic lipase inhibitory activity enhanced and enhanced by acetic acid, epicatechin and oleic acid.
The method according to claim 1, wherein the aging is carried out at a temperature of 60 to 80 ° C for 5 to 10 days, wherein protocatechuic acid, epicatechin and oleic acid are strengthened and enhanced, and alpha-glucosidase inhibitory activity and pancreatic lipase- Gt;
A broth prepared by the manufacturing method according to claim 1 and having alpha-glucosidase inhibiting activity and pancreatic lipase inhibiting activity enhanced and enhanced by protocatechy- cate, epicatechin and oleic acid.
An antioxidative active functional food comprising the bellflower of claim 4 as an active ingredient.
An antidiabetic and anti-obesity functional food comprising the platycodon according to claim 4 as an active ingredient.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170118380A KR102001632B1 (en) | 2017-09-15 | 2017-09-15 | Platycodon radix composition containing high protocatechuic acid, epicatechin, and oleic acid and enhanced inhibition activities of alpha-glucosidase and pancreatic lipase, and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170118380A KR102001632B1 (en) | 2017-09-15 | 2017-09-15 | Platycodon radix composition containing high protocatechuic acid, epicatechin, and oleic acid and enhanced inhibition activities of alpha-glucosidase and pancreatic lipase, and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20190030850A true KR20190030850A (en) | 2019-03-25 |
KR102001632B1 KR102001632B1 (en) | 2019-07-18 |
Family
ID=65907957
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020170118380A KR102001632B1 (en) | 2017-09-15 | 2017-09-15 | Platycodon radix composition containing high protocatechuic acid, epicatechin, and oleic acid and enhanced inhibition activities of alpha-glucosidase and pancreatic lipase, and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102001632B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110563779A (en) * | 2019-09-17 | 2019-12-13 | 西北大学 | jujube pit extract and extraction and separation method and application thereof |
CN112022842A (en) * | 2020-09-23 | 2020-12-04 | 中国农业大学 | Use of protocatechuic acid for the preparation of a medicament for increasing energy metabolism and helping to maintain body temperature in cold environments |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100966613B1 (en) * | 2009-12-21 | 2010-06-29 | 한남대학교 산학협력단 | Method for manufacturing composition comprising arginine derivative or its salt showing the effect of suppressing the elevation of blood sugar level |
KR20150131483A (en) * | 2014-05-15 | 2015-11-25 | 재단법인 발효미생물산업진흥원 | Method for producing Platycodon grandiflorus fermented broth with enhanced antioxidant activity and inhibition activity of alpha-glucosidase |
-
2017
- 2017-09-15 KR KR1020170118380A patent/KR102001632B1/en active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100966613B1 (en) * | 2009-12-21 | 2010-06-29 | 한남대학교 산학협력단 | Method for manufacturing composition comprising arginine derivative or its salt showing the effect of suppressing the elevation of blood sugar level |
KR20150131483A (en) * | 2014-05-15 | 2015-11-25 | 재단법인 발효미생물산업진흥원 | Method for producing Platycodon grandiflorus fermented broth with enhanced antioxidant activity and inhibition activity of alpha-glucosidase |
Non-Patent Citations (1)
Title |
---|
김소영 외 4명. 증숙 및 발효에 따른 도라지의 품질특성 비교. 한국식품저장유통학회. 22(6): pp.851~858(2015.)* * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110563779A (en) * | 2019-09-17 | 2019-12-13 | 西北大学 | jujube pit extract and extraction and separation method and application thereof |
CN112022842A (en) * | 2020-09-23 | 2020-12-04 | 中国农业大学 | Use of protocatechuic acid for the preparation of a medicament for increasing energy metabolism and helping to maintain body temperature in cold environments |
Also Published As
Publication number | Publication date |
---|---|
KR102001632B1 (en) | 2019-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102308755B1 (en) | Making method of low calorie kombucha using fermentated sugar | |
KR101467837B1 (en) | Manufacturing method of fermented red ginseng extract with enhanced ginsenosides Rg3 and antioxidant activity | |
KR101965059B1 (en) | Preparation method of Fabaton soybean leaves composition having high in genistein and daidzein content and a composition having effective components to alleviate climacteric symptoms prepared by the same method | |
KR102386296B1 (en) | Complex-fermented composition of Fabaton soybean leaves and Schisandra chinensis having enhanced anti-diabetic and anti-obesity effects and preparation method thereof | |
KR101482873B1 (en) | Fermentation metabolite of Dendropanax morbiferus produced by liquid-state fermentation and manufacturaring process for the same | |
KR101963978B1 (en) | Composition of fermented sprout ginseng having increased ginsenosides Rh2 and compound K, bioactive components, and preparation method thereof | |
KR101980450B1 (en) | Composition of active wild-cultivated ginseng having increased ginsenoside Rd and compound K, chlorgenic acid and quercetin, and preparation method thereof | |
KR102001632B1 (en) | Platycodon radix composition containing high protocatechuic acid, epicatechin, and oleic acid and enhanced inhibition activities of alpha-glucosidase and pancreatic lipase, and preparation method thereof | |
KR101963046B1 (en) | Composition of processed ginseng having increased ginsenoside compound K, chlorgenic acid and quercetin, and preparation method thereof | |
KR20100074382A (en) | Fermented drinks of ginseng and preparation method thereof | |
KR101917534B1 (en) | Vegetable Brown Sauce with enhanced taste and anti-oxydant property and preparation method thereof | |
KR102464052B1 (en) | Composition of complex-fermented sprout ginseng having increased ginsenoside F2, Rg3, Rd2 and compound K, chlorogenic acid, coumaric acid, catechin and quercetin, and preparation method thereof | |
KR101804727B1 (en) | Method for manufacturing fermented safflower pill | |
KR100403565B1 (en) | a manufacturing process feeds which be made from a Tofuwast redkoji containing monacolin | |
KR101381950B1 (en) | Fermented tea of persimmon leaf and manufacturing method of the same | |
KR102545365B1 (en) | Fermentation composition of mountain-cultivated ginseng having increased ginsenoside Rd, Rc and Protopanaxadiol by using Tricholoma matsutake mycelium and preparation method thereof | |
KR101885994B1 (en) | Manufacture of Shampoo with fermented safflower seed extracts | |
KR102482910B1 (en) | Composition of complex-fermented Fabaton soybean leaves having increased aglycon isoflavones, oleic acid and niacin, and preparation method thereof | |
KR100650063B1 (en) | a yeast manucture method by addition chinesemedicine ingredients | |
KR102557683B1 (en) | Fermentation composition of sprouts of mountain-cultivated ginseng having increased ginsenoside Rg3 and Protopanaxadiol, Rutin, Chlorogenic acid and Essential amid acids by using Tricholoma matsutake mycelium and preparation method thereof | |
KR102564529B1 (en) | Fermentation composition of complex-fermented of Fabaton soybean leaves by using Tricholoma matsutake mycelium and preparation method thereof | |
KR20140084502A (en) | For improving liver function with aloe and Curcuma longa and A method of manufacturing the same and Using the formulations for improving liver function | |
KR102199239B1 (en) | Method for producing salting food for infant having antioxidant and immune enhancement function using fermented product by lactic acid bacteria of Scutellaria baicalensis, Gardenia jasminoides and Carthamus tinctorius | |
US20230357738A1 (en) | Aspergillus oryzae and its application | |
KR102199387B1 (en) | Teriyaki Sauce having high biological active materials and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
N231 | Notification of change of applicant | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right |